ID24014A - Proses dan intermediet untuk pembuatan penghambat-penghambat 5-lipoksigenasa - Google Patents

Proses dan intermediet untuk pembuatan penghambat-penghambat 5-lipoksigenasa

Info

Publication number
ID24014A
ID24014A IDP991082D ID991082D ID24014A ID 24014 A ID24014 A ID 24014A ID P991082 D IDP991082 D ID P991082D ID 991082 D ID991082 D ID 991082D ID 24014 A ID24014 A ID 24014A
Authority
ID
Indonesia
Prior art keywords
lipoxxygenash
intermediety
obstacles
making
lipoxxygenash obstacles
Prior art date
Application number
IDP991082D
Other languages
English (en)
Indonesian (id)
Inventor
Charles Kwok-Fung Chiu
Ravi Mysore Shanker
Douglas John Meldrum Allen
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ID24014A publication Critical patent/ID24014A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
IDP991082D 1998-12-22 1999-11-22 Proses dan intermediet untuk pembuatan penghambat-penghambat 5-lipoksigenasa ID24014A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11322198P 1998-12-22 1998-12-22

Publications (1)

Publication Number Publication Date
ID24014A true ID24014A (id) 2000-06-22

Family

ID=22348241

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP991082D ID24014A (id) 1998-12-22 1999-11-22 Proses dan intermediet untuk pembuatan penghambat-penghambat 5-lipoksigenasa

Country Status (22)

Country Link
US (1) US6194585B1 (ko)
EP (1) EP1029865B1 (ko)
JP (2) JP3468729B2 (ko)
KR (1) KR100362789B1 (ko)
CN (1) CN1258675A (ko)
AR (1) AR019497A3 (ko)
AT (1) ATE265460T1 (ko)
AU (1) AU6539199A (ko)
BR (1) BR9905918A (ko)
CA (1) CA2289422A1 (ko)
CZ (1) CZ453699A3 (ko)
DE (1) DE69916778D1 (ko)
HU (1) HUP9904282A3 (ko)
ID (1) ID24014A (ko)
IL (1) IL132897A0 (ko)
IN (1) IN187165B (ko)
PL (1) PL337397A1 (ko)
RU (1) RU2181722C2 (ko)
TR (1) TR199903204A2 (ko)
TW (1) TW455586B (ko)
YU (1) YU59399A (ko)
ZA (1) ZA997113B (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4569187B2 (ja) * 2004-06-17 2010-10-27 宇部興産株式会社 4−シアノテトラヒドロピランの製法
EP1834953A1 (en) * 2006-03-14 2007-09-19 Ranbaxy Laboratories Limited Tetrahydropyrane derivatives as 5-lipoxygenase inhibitors
UA92833C2 (en) * 2006-11-27 2010-12-10 Пфайзер Продактс Инк. Pyrazole analogues
NZ624963A (en) 2009-04-29 2016-07-29 Amarin Pharmaceuticals Ie Ltd Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0462830B1 (en) * 1990-06-21 1995-10-18 Zeneca Limited Cyclic ether derivatives
IE913866A1 (en) * 1990-11-28 1992-06-03 Ici Plc Aryl derivatives
EP0505122A1 (en) * 1991-03-21 1992-09-23 Zeneca Limited Alpha, alpha-dialkylbenzyl derivatives
EP0540165A1 (en) * 1991-10-03 1993-05-05 Zeneca Limited Alkanoic acid derivatives
AU685122B2 (en) * 1993-06-14 1998-01-15 Pfizer Inc. Imidazole lipoxygenase inhibitors
US5883106A (en) * 1994-10-18 1999-03-16 Pfizer Inc. 5-lipoxygenase inhibitors
SK281577B6 (sk) * 1994-10-18 2001-05-10 Pfizer Inc. Heterocyklické zlúčeniny a farmaceutický prostriedok na ich báze

Also Published As

Publication number Publication date
JP3468729B2 (ja) 2003-11-17
AR019497A3 (es) 2002-02-20
AU6539199A (en) 2000-06-29
EP1029865A2 (en) 2000-08-23
HUP9904282A2 (hu) 2000-12-28
EP1029865A3 (en) 2000-11-08
MX9912076A (ko) 2000-04-30
IN187165B (ko) 2002-02-23
RU2181722C2 (ru) 2002-04-27
EP1029865B1 (en) 2004-04-28
TW455586B (en) 2001-09-21
DE69916778D1 (de) 2004-06-03
YU59399A (sh) 2002-11-15
HU9904282D0 (en) 2000-01-28
TR199903204A2 (xx) 2000-07-21
KR100362789B1 (ko) 2002-11-30
KR20000052537A (ko) 2000-08-25
IL132897A0 (en) 2001-03-19
PL337397A1 (en) 2000-07-03
CA2289422A1 (en) 2000-06-22
JP2004002415A (ja) 2004-01-08
ATE265460T1 (de) 2004-05-15
BR9905918A (pt) 2000-09-26
US6194585B1 (en) 2001-02-27
JP2000191654A (ja) 2000-07-11
CN1258675A (zh) 2000-07-05
HUP9904282A3 (en) 2001-04-28
ZA997113B (en) 2001-05-15
CZ453699A3 (cs) 2000-07-12

Similar Documents

Publication Publication Date Title
ID19290A (id) Turunan-turunan propiofenon dan proses pembuatannya
ID15947A (id) Senyawa fenol dan proses pembuatannya
ID27408A (id) Benda penyerap dan proses pembuatannya
ID28728A (id) Komposisi dan proses pengkrepan
ID17307A (id) Komposisi oral dan proses pembuatannya.
ID26172A (id) Proses pembuatan surfaktan-surfaktan alkilbenzenasulfonat dan produk-produknya
ID27859A (id) Tampon dan metoda pembuatannya
ID18047A (id) Proses pembuatan bahan antara untuk florfenikol
ID16930A (id) Peralatan fotovoltaik dan proses untuk produksinya
ID26102A (id) Proses pembuatan senyawa-senyawa stilbena
ID23963A (id) Proses pembuatan vinil asetat
ID19385A (id) Adesif termosetting dan metoda pembuatannya
ID22641A (id) Proses pembuatan e-kaprolaktam
ID27275A (id) Intermediet dan proses untuk pembuatan olanzapin
ID15992A (id) Papan lamina dan proses pembuatannya
ID24600A (id) Proses pembuatan poliol-poliol polieter dan poliol yang dibuat bersamaan
ID26902A (id) Proses dan radas untuk pembuatan melamina
ID16923A (id) Komposisi-komposisi bitumen dan proses pembuatannya
ID28025A (id) Metode pembuatan aminonitril dan diamina
ID25901A (id) Proses pembuatan 4-aminometil-pirolidin-3-on terlindung
ID23304A (id) Turunan-turunan diaza-spiro [3,5] nonana, proses pembuatan dan penggunaannya
ID24173A (id) 1,2,3,4,5,6 heksahidro-2-6-metano-3-benzazosin-10-ol, proses pembuatan dan penggunannya untuk obat-obatan
ID22222A (id) Proses pembuatan tiazolidinadiona tersubstitusi
ID22367A (id) Lampu dan metoda pembuatannya
ID29140A (id) Manisan tepung yang diekspansi dan proses pembuatannya